Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. (Q50613976)

16 March 2018

title

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. (English)

1 reference

16 March 2018

0 references

1 reference

3

1 reference

16 March 2018

Richard Mayeux

8

object named as

R Mayeux

1 reference

16 March 2018

4

K Marder

1 reference

16 March 2018

Ming-Xin Tang

1

object named as

M X Tang

1 reference

16 March 2018

author name string

D Jacobs

2

1 reference

16 March 2018

P Schofield

5

1 reference

16 March 2018

B Gurland

6

1 reference

16 March 2018

H Andrews

7

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 August 1996

1 reference

16 March 2018

published in

The Lancet

1 reference

16 March 2018

volume

348

1 reference

16 March 2018

page(s)

429-432

1 reference

16 March 2018

issue

9025

1 reference

16 March 2018

Reduced mortality associated with long-term postmenopausal estrogen therapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Epidemiology of clinically diagnosed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Senile dementia-Alzheimer's type and estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Age-specific incidence of Alzheimer's disease in a community population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

A case-control study of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Presumptive Estrogen Target Neurons Express mRNAs for both the Neurotrophins and Neurotrophin Receptors: A Basis for Potential Developmental Interactions of Estrogen with the Neurotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Clinical application of apolipoprotein E genotyping to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

10.1016/S0140-6736(96)03356-9

Identifiers

DOI

1 reference

16 March 2018

PubMed ID

8709781

1 reference

16 March 2018